Precigen
PGEN
130 hedge funds and large institutions have $95.9M invested in Precigen in 2024 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 42 increasing their positions, 38 reducing their positions, and 13 closing their positions.
773% more call options, than puts
Call options by funds: $777K | Put options by funds: $89K
23% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 13
11% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 38
7% more capital invested
Capital invested by funds: $89.7M → $95.9M (+$6.21M)
0% more funds holding
Funds holding: 130 → 130 (0)
0.81% less ownership
Funds ownership: 24.87% → 24.06% (-0.81%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Patient Capital Management
Baltimore,
Maryland
|
+$1.05M |
| 2 |
GC
GMT Capital
Atlanta,
Georgia
|
+$971K |
| 3 |
LA
LexAurum Advisors
Overland Park,
Kansas
|
+$221K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$206K |
| 5 |
Renaissance Technologies
New York
|
+$189K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.78M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.37M |
| 3 |
JP Morgan Chase
New York
|
-$314K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$213K |
| 5 |
SMH
Sanders Morris Harris
Houston,
Texas
|
-$211K |
PGEN Hedge Fund Activity: Q2 2024 in Review
130 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Precigen (PGEN) for Q2 2024, worth a combined $95.9M — up 6.9% from $89.7M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new PGEN positions and 13 closed out — a net gain of 3 holders — while 42 added to existing stakes and 38 trimmed.
The largest buyer was Patient Capital Management, adding an estimated $1.05M. The largest seller was Millennium Management, cutting an estimated $1.78M.
- 130 institutional investors held Precigen (PGEN) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $95.9M of Precigen stock for Q2 2024, up 6.9% quarter-over-quarter.
- 16 funds opened new Precigen positions in Q2 2024 and 13 closed out, a net change of +3 holders.
- The largest Precigen buyer in Q2 2024 was Patient Capital Management, an estimated $1.05M added.
- The largest Precigen seller in Q2 2024 was Millennium Management, an estimated $1.78M sold.
Based on aggregated 13F filings for Q2 2024.